Whilst both hCG and GnRH agonists can trigger oocyte maturation, they have very different pharmacokinetic properties, making the use of hCG as a trigger one of the main risk factors for developing OHSS. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.